Spyre CFO Sells Shares, Plans More

The provided excerpts do not state how many Syre Therapeutics shares Scott L. Burrows sold. The Form 4 excerpt describes an option award giving him the right to purchase 404,857 shares and reports post-transaction holdings of 312,357 options and 79,762 shares of common stock; the related Rule 144 excerpts contain filing instructions but no sale quantities.
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?




